2025 annual financial data
Cogent Biosciences 2025 Operating margin
Cogent Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -333,363,000 USD and net income was -328,937,000 USD.
Operating cash flow was -264,444,000 USD.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -333,363,000 USD
- Net income
- -328,937,000 USD
- Operating cash flow
- -264,444,000 USD